Answers are grounded in this paper and cite their sources.
Evaluates microalbuminuria screening using Albusure Test in diabetic patients, indicating potential benefits.
All diabetic patients should be screened for early signs of diabetic nephropathy; because it is a prognostic factor in the disease. The albusure test^®(AT), a latex agglutination nephelometric immunoassay, is a rapid and low cost test for the detection of microalbuminuria of 30 mg/L or more. We compared the results of AT and of radioimmunoassay (RIA) for urinary albumin to evaluate the clinical utility of AT using fresh urine samples from 74 diabetic patients without persistent proteinuria and from 11 healthy subjects. Urinary albumin levels were 6.0 ± 2.3 mg/L in the healthy subjects, 11.0 ± 8.7 mg/L in the AT-negative group (n = 61), and 38.1 ± 10.2 mg/L in the AT-positive group (n = 13). Using a cut-off value of 30 mg/L by RIA, the rate of coincidence between AT and RIA was 89.2%, although five subjects were false-positive by AT, and three were false-negative. These results show that AT may provide a useful monitor for microalbuminuria, a reliable early marker of diabetic nephropathy.
No takes yet. Share an insight, caveat, or question.
ZANG et al. (1992) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: